Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
136.87
+3.43 (+2.57%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 2, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,661,662
Open
133.71
Bid (Size)
136.60 (2)
Ask (Size)
138.06 (1)
Prev. Close
133.44
Today's Range
133.50 - 136.97
52wk Range
131.10 - 168.11
Shares Outstanding
N/A
Dividend Yield
3.80%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AbbVie Unusual Options Activity
June 02, 2023
Via
Benzinga
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
June 02, 2023
Big Pharma is facing a patent cliff that could siphon off billions in revenue.
Via
Investor's Business Daily
Performance
YTD
-15.71%
-15.71%
1 Month
-7.54%
-7.54%
3 Month
-11.86%
-11.86%
6 Month
-16.51%
-16.51%
1 Year
-6.59%
-6.59%
More News
Read More
7 Best Dividend Stocks to Buy Now in June 2023
June 01, 2023
Via
The Motley Fool
Mark Cuban Helping Lower Cost Of Bestselling Humira With Cost Plus Drug Company: 'The Game Just Changed'
June 01, 2023
Via
Benzinga
Why Is AbbVie Stock Trading Down Today?
June 01, 2023
Via
Benzinga
Why AbbVie and Amgen Are Moving Lower Today
June 01, 2023
Via
The Motley Fool
AbbVie Unusual Options Activity
May 30, 2023
Via
Benzinga
2 Top Dividend Kings to Buy for the Long Haul
May 25, 2023
Via
The Motley Fool
2 Dividend Kings on Sale That Are Yielding More Than 4%
May 25, 2023
Via
The Motley Fool
Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields
May 24, 2023
Via
Benzinga
AbbVie Unusual Options Activity
May 23, 2023
Via
Benzinga
Clinical Triumph: MEI Pharma's Voruciclib Demonstrates Encouraging Activity in AML Patients
May 23, 2023
Via
Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,200 Today
May 23, 2023
Via
Benzinga
Why Ironwood Pharmaceuticals Stock Bumped Higher Today
May 22, 2023
Via
The Motley Fool
AbbVie Unusual Options Activity
May 22, 2023
Via
Benzinga
What Does AbbVie's Debt Look Like?
May 17, 2023
Via
Benzinga
This Is What Whales Are Betting On AbbVie
May 17, 2023
Via
Benzinga
P/E Ratio Insights for AbbVie
May 17, 2023
Via
Benzinga
VectivBio Stock Catapults 38% After Ironwood Agrees To Buy It For $1 Billion
May 22, 2023
Via
Investor's Business Daily
3 Relatively Safe Stocks to Buy if a Recession Is on the Way
May 20, 2023
Via
The Motley Fool
3 No-Brainer Dividend Stocks to Buy With $1,000 Right Now
May 20, 2023
Via
The Motley Fool
FDA Approves AbbVie/Genmab's Cancer Drug As First Bispecific Antibody For Type Of Lymphoma In Adult Patients
May 19, 2023
Via
Benzinga
FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq
May 19, 2023
Via
Benzinga
Apple Thwarts $2B In Fraud Transactions, UBS Takes $17B Hit From 'Hasty Credit Suisse Takeover,' Verizon Streamlines Unlimited Data Plans: Today's Top Stories
May 17, 2023
Via
Benzinga
One More Quits US Pharma Lobby Group: AstraZeneca Follows Teva, AbbVie Footsteps
May 17, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.